Experimental Drug Shows Promise for Drug-Resistant Lung Cancer - Philly.com

[INCIID News Feed]

Medscape
<img alt="" height="1" width="1" />
Experimental Drug Shows Promise for Drug-Resistant Lung Cancer
Philly.com
WEDNESDAY, March 26, 2014 (HealthDay News) -- A new drug may help lung cancer patients when they become resistant to the first-line medication crizotinib, researchers find. Although crizotinib (brand name Xalkori) causes regression of a specific type of ...
Novartis Drug Shows Promise in Rare Lung CancerWall Street Journal
New Agent Offers Promise for ALK-Positive NSCLCMedscape
Relapsed NSCLC Yields to ALK InhibitorMedPage Today
The Oncology Report -NASDAQ
all 18 news articles &raquo;


More...